Anne Maria Beukers

Dr. Anne Maria Beukers


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2022 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
ABAnne Maria Beukers
Anne Maria Beukers
JRJamy Adriana Catharina de Ruijter
Jamy Adriana Catharina de Ruijter
SLStephan Alexander Loer
Stephan Alexander Loer
AVAlexander Vonk
Alexander Vonk
CBCarolien Suzanna Enna Bulte
Carolien Suzanna Enna Bulte
Colloid oncotic pressure (COP) is an important factor in cardiac surgery, owing to its role in haemodilution. The effect of cardiopulmonary bypass prime fluids on the COP is unknown. In this study, the effect of crystalloid and colloid prime fluids, with or without retrograde autologous priming (RAP), on the COP during elective cardiac surgery was evaluated. Randomized controlled trials and prospective clinical trials comparing crystalloid and colloid priming fluids or with RAP were selected. The primary outcome was the COP; secondary outcomes were fluid balance, fluid requirements, weight gain, blood loss, platelet count and transfusion requirements. From 1582 records, 29 eligible studies were identified. COPs were comparable between gelofusine and hydroxyethyl starch (HES) during bypass [mean difference (MD): 0.69; 95% confidence interval (CI): −2.05, 3.43; P = 0.621], after bypass (MD: −0.11; 95% CI: −2.54, 2.32; P = 0.930) and postoperative (MD: −0.61; 95% CI: −1.60, 0.38; P = 0.228). Fluid balance was lower with HES than with crystalloids. RAP reduced transfusion requirements compared with crystalloids. Blood loss was comparable between groups. COPs did not differ between crystalloids and colloids. As a result of increased transcapillary fluid movement, fluid balance was lower with HES than with crystalloids. Haematocrit and transfusion requirements were comparable between groups. However, the latter was lower when RAP was applied to crystalloid priming compared with crystalloids alone. Finally, no differences in blood loss were observed between the groups.

26 March 2024 in Trials
Verified
Journal Article
Open access
PDF file
ABAnne Maria Beukers
Anne Maria Beukers
CBCarolien S. E. Bulte
Carolien S. E. Bulte
RBRuben J. Bosch
Ruben J. Bosch
SESusanne Eberl
Susanne Eberl
CBCharissa E. van Den Brom
Charissa E. van Den Brom
AVAlexander B. A. Vonk
Alexander B. A. Vonk
Background: Acute microcirculatory perfusion disturbances and organ edema are important factors leading to organ dysfunction during cardiac surgery with cardiopulmonary bypass (CPB). Priming of the CPB system with crystalloid or colloid fluids, which inevitably leads to hemodilution, could contribute to this effect. However, there is yet no optimal evidence-based strategy for this type of priming. Hence, we will investigate different priming strategies to reduce hemodilution and preserve microcirculatory perfusion. Methods: The PRIME study is a single-center double-blind randomized trial. Patients undergoing elective coronary artery bypass graft surgery with CPB will be randomized into three groups of prime fluid strategy: (1) gelofusine with crystalloid, (2) albumin with crystalloid, or (3) crystalloid and retrograde autologous priming. We aim to include 30 patients, 10 patients in each arm. The primary outcome is the change in microcirculatory perfusion. Secondary outcomes include colloid oncotic pressure; albumin; hematocrit; electrolytes; fluid balance and requirements; transfusion rates; and endothelial-, glycocalyx-, inflammatory- and renal injury markers. Sublingual microcirculatory perfusion will be measured using non-invasive sidestream dark field video microscopy. Microcirculatory and blood measurements will be performed at five consecutive time points during surgery up to 24 h after admission to the intensive care unit. Discussion: PRIME is the first study to assess the effect of different prime fluid strategies on microcirculatory perfusion in cardiac surgery with CPB. If the results suggest that a specific crystalloid or colloid prime fluid strategy better preserves microcirculatory perfusion during on-pump cardiac surgery, the current study may help to find the optimal pump priming in cardiac surgery. Trial registration: ClinicalTrials.gov NCT05647057. Registered on 04/25/2023. ClinicalTrials.gov PRS: Record Summary NCT05647057, all items can be found in the protocol.

8 August 2023 in Perfusion
Verified
Journal Article
Open access
ABAnne Maria Beukers
Anne Maria Beukers
JHJuan de Villiers Hugo
Juan de Villiers Hugo
RHRenard Gerardus Haumann
Renard Gerardus Haumann
JBJan Willem Taco Boltje
Jan Willem Taco Boltje
EIEvy Loan Khiam Ie
Evy Loan Khiam Ie
AVAlexander Vonk
Alexander Vonk
Objective: In cardiac surgery, colloid oncotic pressure (COP) is affected by haemodilution that results from composition and volume of prime fluid of cardiopulmonary bypass (CPB). However, the extent to which different priming strategies alter COP is largely unknown. Therefore, we investigated the effect of different priming strategies on COP in on-pump cardiac surgery. Methods: Patients ( n = 60) were divided into 3 groups ( n = 20 each), based on the center in which they were operated and the specific prime fluid strategy used in that center during the inclusion period. CPB prime fluids were either gelofusine-, albumin-, or crystalloid based, the latter two with or without retrograde autologous priming. Results: In all groups, COP was lowest after weaning from CPB and one hour after CPB. Between groups, COP was lowest with gelofusine prime fluid (16.4, 16.8 mmHg, respectively) compared with crystalloids (MD: -1.9; 95% CI:-3.6, -0.2; p = .02 and MD: -2.4, 95% CI: -4.2, -0.7; p = .002) and albumin (MD: -1.8, 95% CI: -3.5, -0.50; p = .041 and MD: -2.4, 95% CI: -4.1, -0.7; p = .002). In all groups, the decrease in COP one hour after bypass compared to baseline correlated positively with fluid balance at the end of surgery ( p < .001). Conclusions: COP significantly decrease during CPB surgery with the largest decrease in COP at the end of surgery, while at the same time fluid balance increases. We suggest that prime fluid strategy should be carefully selected when maintenance of COP during cardiac surgery is desirable.

16 May 2026 in Perfusion
Verified
Journal Article
Open access
ABAnne Maria Beukers
Anne Maria Beukers
JSJord C. Seegers
Jord C. Seegers
NHNikki van Haasteren
Nikki van Haasteren
MBMeike Brouwers
Meike Brouwers
RBRuben J. Bosch
Ruben J. Bosch
AVAlexander Vonk
Alexander Vonk
Objectives: Cardiopulmonary bypass (CPB) impairs endothelial function, causing oedema and disturbed microcirculatory perfusion, that contribute to organ dysfunction following cardiac surgery. We hypothesised that the composition of CPB prime fluids with either albumin or gelofusine preserves sublingual microcirculatory perfusion in patients undergoing coronary artery bypass graft surgery. Methods: Thirty-four patients were subjected to CPB primed with 1500 ml of either albumin/ringers (n = 8, gelofusine/ringers ( n = 11), or solely ringers plus retrograde autologous priming (RAP) ( n = 15). All solutions included 100 ml of mannitol. The primary outcome was perfused vessel density (PVD) assessed after anaesthesia induction, aortic cross-clamping, weaning from CPB, upon intensive care unit (ICU) arrival and 24 h after ICU arrival. Results: CPB immediately impaired PVD across all groups, persisting until ICU arrival. The decrease in PVD was most profound with albumin/ringers (estimated mean difference between baseline and ICU arrival −7.56 [95% CI -11.53 to −3.59] mm . mm -2 ), compared to gelofusine/ringers (−4.10 [−7.53 to −0.67] mm . mm -2 ), and ringers/RAP (−3.77 [-6.64 to −0.90] mm . mm -2 ), without differences between groups ( p = 0.41). In patients receiving gelofusine/ringers COP was preserved after aortic cross clamping. Concentration of inflammatory (interleukin-6) and endothelial damage markers (angiopoietin-2) were increased with albumin/ringers compared with gelofusine/ringers and ringers plus RAP. Conclusion: In this exploratory physiological study, all of the three CPB priming strategies, albumin/ringers, gelofusine/ringers or ringers plus RAP, similarly induced perioperative microcirculatory dysfunction in patients undergoing CABG surgery.

26 August 2026 in Anesthesia & Analgesia
Verified
Journal Article
Open access
ABAnne Maria Beukers
Anne Maria Beukers
MHMarkus W. Hollmann
Markus W. Hollmann
SESusanne Eberl
Susanne Eberl
HHHenning Hermanns
Henning Hermanns
Was not provided for this article.

8 April 2025 in medRxiv
Verified
Preprint
Open access
PDF file
ABAnne Maria Beukers
Anne Maria Beukers
JSJord Seegers
Jord Seegers
NHNikki van Haasteren
Nikki van Haasteren
MBMeike Brouwers
Meike Brouwers
RBRuben J. Bosch
Ruben J. Bosch
AVAlexander B.A. Vonk
Alexander B.A. Vonk
Introduction: Cardiopulmonary bypass (CPB) can cause endothelial dysfunction, leading to edema formation, disturbed microcirculatory perfusion, and impaired tissue oxygenation. Together, these factors contribute to organ dysfunction in patients undergoing cardiac surgery. We hypothesis that the composition of CPB prime fluids influences endothelial function and prevents microcirculatory dysfunction. We assessed the impact of three different CPB prime fluid strategies on microcirculatory perfusion in adult patients undergoing coronary artery bypass graft surgery. Methods: Thirty-four patients were subjected to CPB primed with 1500 mL of either albumin/ringers, gelofusine/ringers, or solely ringers plus retrograde autologous priming (RAP). All three priming solutions included 100 mL of mannitol. The primary outcome was perfused vessel density (PVD) assessed by sublingual microcirculatory imaging at 5 time points (after anesthesia induction, aortic cross-clamping, weaning from CPB, upon intensive care unit arrival (ICU), and 24 hrs after ICU arrival) as main marker of microcirculatory perfusion. Secondary outcomes included total vessel density, proportion of perfused vessels, microvascular flow-, and heterogeneity index (as additional markers of microcirculatory perfusion), colloid oncotic pressure (COP), albumin, glycocalyx shedding-, endothelial-, inflammation- and renal injury markers, hemoglobin, hematocrit, hemolysis index, transfusion volumes, fluid balance and fluid requirements. Results: CPB immediately impaired PVD across all groups (albumin/ringers estimated mean difference between baseline and arrival ICU -7.56 95% CI [-11.53 to -3.59] mm mm −2 , gelofusine/ringers -4.10 [-7.53 to -0.67] mm mm −2 , and ringers plus RAP -3.77 [-6.64 to -0.90] mm mm −2 ), persisting until ICU arrival without differences between groups. In patients receiving gelofusine/ringers COP was preserved after aortic cross clamping, and was associated with lower intraoperative fluid requirements and fluid balances compared to those receiving albumin/ringers or ringers plus RAP. Levels of inflammatory (interleukin-6) and endothelial damage markers (angiopoietin-2) were higher in patients receiving albumin/ringers compared with those receiving gelofusine/ringers, and ringers plus RAP. Conclusion: All of the three CPB priming strategies - albumin/ringers, gelofusine/ringers or ringers plus RAP – similarly induced perioperatieve microcirculatory dysfunction in patients undergoing CABG surgery. These findings suggest that none of these prime fluid strategies confers protection for microcirculatory perfusion during cardiac surgery. Albumin priming resulted in increased inflammatory markers at 24 hrs after surgery. Trial registration: ClinicalTrials.gov, NCT05647057 . Registered on 04/25/2023. ClinicalTrials.gov PRS: Record Summary NCT05647057 , all items can be found in the protocol.